May 07, 2026 article Open access Targeting solid tumors with TCR-T cells: mechanisms, progress, and challenges Frontiers in Oncology DOI: 10.3389/fonc.2026.1810903 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 1 References 3 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia 2022 Science Translational Medicine article Medicine CAR-T cell therapy research Open access cited by 2 patents 204 citations Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure 2022 OncoImmunology article Medicine CAR-T cell therapy research Open access cited by 2 patents 60 citations Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies 2025 Nature Communications article Medicine CAR-T cell therapy research Open access 18 citations 3 results